Twitter Linkedin
Search
Close
Twitter Linkedin
Search
Close
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Working at Boyds
    • Join Us
  • Services
    • Product Development
      • Due Diligence
      • Toxicology Consulting
    • Regulatory Affairs
      • Regulatory and Medical Writing
      • Toxicology Consulting
    • Clinical Operations
      • Study Start-Up
      • Site Monitoring
      • Clinical Project Management
      • Biostatistics
    • Clinical and Medical Affairs
      • Scientific and Medical Advice
      • Medical Monitoring
      • Safety and Pharmacovigilance
  • Regulatory Updates
  • Latest
    • News
    • Blogs
    • Events
  • Resources
  • Contact
Menu
  • Home
  • About
    • About Boyds
    • Why Boyds
    • Our Team
    • Vision and Values
    • Working at Boyds
    • Join Us
  • Services
    • Product Development
      • Due Diligence
      • Toxicology Consulting
    • Regulatory Affairs
      • Regulatory and Medical Writing
      • Toxicology Consulting
    • Clinical Operations
      • Study Start-Up
      • Site Monitoring
      • Clinical Project Management
      • Biostatistics
    • Clinical and Medical Affairs
      • Scientific and Medical Advice
      • Medical Monitoring
      • Safety and Pharmacovigilance
  • Regulatory Updates
  • Latest
    • News
    • Blogs
    • Events
  • Resources
  • Contact

Latest news & insights

Boyds adds medical writer, Vicky Wheeldon, to growing Regulatory Affairs team

Read More

Julie Warner: A regulatory roadmap to translation of ATMPs

Read More

Boyds bolsters clinical operations team as demand for clinical trial expertise and support surges

Read More

Dr Karen Mullen appointed as Chief Medical Officer

Read More

Strong growth in the US boosts revenue for Boyds

Read More

Boyds boosts specialist clinical expertise with appointment of Dr Harriet Gray Stephens

Read More

Katy Rudnick awarded Aiko Maruya award for Excellence in Regulatory Science

Read More

Pippa Bjaaland graduates with MSc in Cancer and Clinical Oncology with distinction.

Read More

Eamonn McGowran: Medical Devices Regulatory Specialist joins Boyds

Read More

US Agent Services

Read More

Boyds goes for growth with key appointment of Dr Neil Fish

Read More

Boyds expands product development team

Read More

Newsletter Sign-up

Sign up to our monthly newsletter to stay up to date with the latest news and views from Boyds.
Sign Up

Speak to a member of the team today

Contact Us

Contact Us

T +44 (0)1270 270010
E info@boydconsultants.com

Twitter Linkedin

Services

  • Product Development
  • Regulatory Affairs
  • Clinical Operations
  • Clinical and Medical Affairs

Tweets

Orphan Drug Designation in the US: Why does it matter?

Read our … latest article, written by Katy Rudnick, investigating how and why small pharmas should get onboard to help develop medicines effective in the treatment of orphan diseases. https://t.co/X6g4HLDfGM

Reply on Twitter 1526851531705749506Retweet on Twitter 15268515317057495061Like on Twitter 15268515317057495062Twitter 1526851531705749506

Newsletter Sign-up

Sign up to our monthly newsletter to stay up to date with the latest news and views from Boyds.

Sign Up

Services

  • Product Development
  • Regulatory Affairs
  • Clinical Operations
  • Clinical & Medical Affairs

Contact Us

T +44 (0)1270 270010
E info@boydconsultants.com

Twitter Linkedin

Newsletter Sign-up

Sign up to our monthly newsletter to stay up to date with the latest news and views from Boyds.

Sign Up

©2022 Boyds. Boyds is a trading name of Alan Boyd Consultants Ltd. Registered in England & Wales 5395927

Privacy Policy      Contact

arrow